Private firm 23andMe Inc and Genentech on Tuesday announced that they have signed a USD 60 million agreement under which they will jointly work on generating whole genome sequencing data for the people with Parkinson's disease Both the |
23andme signs a $60 million deal with genentech for parkinson's database - thetimesgazette.com23andme signs a $60 million deal with genentech for parkinson's database founded by anne wojcicki in 2006 23andme a personal genetics company with the genetic information of over 800000 in its database has signed a deal worth $60 million with |
23andme, genentech to analyze 3000 parkinson's genomes - reuters.comreuters privately held 23andme inc and genentech said on tuesday they will work together to generate whole genome sequencing data for about 3000 people with parkinson's disease in order to identify new therapeutic targets for treating the |
23andme, genentech partner on parkinson's - the-scientist.comfirms enter a multiyear deal for the analysis of wholegenome sequence data with an eye toward drug discovery for parkinson's disease by tracy vence january 7 2015 comment print link this stumble tweet this istock fotohunterin a deal |
genentech files nda for skin cancer treatment - bidnessetc.comgenentech a usbased biotech subsidiary of roche holding ltd adr otcmktsrhhby announced monday that it has filed a new drug application nda with the us food and drug administration fda for its pipeline drug cobemetinib cobemetinib |
miami-based opko health partners with pfizer in $295 million deal - miamiherald.commiamibased opko health has partnered with pharmaceutical giant pfizer to develop and commercialize an opko treatment for growthhormone deficiency that could replace daily injections with weekly ones the companies announced monday opko will |
$135 million deal proposed in new england compounding pharmacy ... - bostonglobe.comthe fund to compensate victims of a deadly 2012 meningitis outbreak linked to tainted drugs at a nowdefunct framingham pharmacy could increase by more than $35 million lawyers involved in bankruptcy negotiations said wednesday under terms of a |
abbott completes $250 million deal for topera - chicago.suntimes.comnorth chicagobased abbott paid $250 million for the company with the possibility of future payments depending on performance the topera acquisition gives abbott a foundational entry in the large highgrowth electrophysiology market with breakthrough |
23andme and genentech collaborate for parkinson's treatment research - diabetesinsider.comgenentech and geneticstesting startup 23andme have come together to launch a research to find new treatments for parkinson's disease the companies announced on tuesday this is the first deal that 23andme has bagged with a major pharmaceutical |
surprise! with $60 million genentech deal, 23andme has a business plan - forbes.coma deal being announced today with genentech points the way for 23andme the personal genetics company backed by facebook billionaire yuri milner and google ventures to become a sustainable business – even if the company's discussions with the us |
23andme gets thumbs up from big pharma with $50 million genentech deal - theverge.comdespite setbacks from regulators 23andme is attracting serious interest from heavyhitters in the pharmaceutical industry the ambitious genetics startup has received a first payment of $10 million from biotech company genentech in exchange for genetic |
Thứ Tư, 7 tháng 1, 2015
23andMe, Genentech sign USD 60 million deal on Parkinson's treatment
